drugset / Trial / NCT04066296
Outcomes for Lumbar Decompressions With Use of Liposomal Bupivicaine
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Evaluate the benefit of using liposomal bupivicaine in lumbar laminectomies in terms of length of stay, IV narcotic use, 30-day narcotic use, visual analog score (VAS) and 30-day readmissions
Timeline
- Start
- 2019-09-08
- Primary completion
- 2024-12-31
- Completion
- 2025-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Bupivacaine | Other / unclassified | — | — |